On ECHEMI
Home > Drugs > Vildagliptin Registered Holders
Vildagliptin structure

Vildagliptin structure

Vildagliptin

Vildagliptin (LAF-237; NVP-LAF 237) inhibits DPP-4 with IC50 of 2.3 nM.IC50 Value: 2.3 nM[1]Target: DPP-4in vitro: Vildagliptin is an N-substituted glycyl-2-cyanopyrrolidine (figure 2). It is a potent competitive and reversible inhibitor of human and rodent DPP-4 in vitro, with a median inhibitory concentration (IC50) ~2-3 nmol/L. Importantly, vildagliptin inhibits DPP-4 with high specificity relative to other similar peptidases where its IC50 exceeds 200 mol/L [1].in vivo: Compared to a

Find 51 Related Holders

INNOVARE LABS PRIVATE LTD
United States United States

API Registration Country

API Active
CHIERON A INGREDIENTS PRIVATE LTD
United States United States

API Registration Country

API Active
MANKIND PHARMA LTD
United States United States

API Registration Country

API Active
OPTIMUS DRUGS PRIVATE LTD
United States United States

API Registration Country

API Active
HONOUR LAB LTD
United States United States

API Registration Country

API Active
VIWIT PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
LEE PHARMA LTD
United States United States

API Registration Country

API Active
JUBILANT PHARMOVA LTD
United States United States

API Registration Country

API Active
HIKAL LTD
United States United States

API Registration Country

API Active
Exemed Pharmaceuticals
United States United States

API Registration Country

API Active
Recommended Suppliers of Vildagliptin
View 145 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.